Mereo BioPharma Group (MREO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Mereo BioPharma Group

    NASDAQ: MREO · Real-Time Price · USD
    2.04
    -0.01 (-0.49%)
    At close: Oct 03, 2025, 3:59 PM
    2.06
    0.98%
    After-hours: Oct 03, 2025, 05:54 PM EDT

    Mereo BioPharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 69.8M 57.42M 56.33M 94.3M
    Short-Term Investments
    		 n/a n/a 51.1M 569K
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a -25.95M -27.09M
    Receivables
    		 3.25M 3.73M 2.75M 1.42M
    Inventory
    		 n/a n/a -2.67M -1.82M
    Other Current Assets
    		 507K 1.98M 1.43M 2.23M
    Total Current Assets
    		 74.76M 63.76M 62.13M 99.32M
    Property-Plant & Equipment
    		 984K 1.65M 1.83M 2.53M
    Goodwill & Intangibles
    		 643K 1.09M 24.12M 24.56M
    Total Long-Term Assets
    		 1.63M 2.74M 25.95M 27.09M
    Total Assets
    		 76.39M 66.5M 88.08M 126.42M
    Account Payables
    		 2.44M 2.35M 3.49M 2.29M
    Deferred Revenue
    		 n/a n/a n/a 8.37M
    Short-Term Debt
    		 5.54M n/a 11.02M n/a
    Other Current Liabilities
    		 -413K 2.37M 5.82M 5.62M
    Total Current Liabilities
    		 13.85M 9.49M 24.68M 12.54M
    Long-Term Debt
    		 n/a 4.39M n/a n/a
    Other Long-Term Liabilities
    		 1.39M 1.18M 54K 36.04M
    Total Long-Term Liabilities
    		 1.57M 6.48M 1.53M 25.87M
    Total Liabilities
    		 15.42M 15.96M 26.21M 38.41M
    Total Debt
    		 6.43M 5.95M 12.77M 16.76M
    Book Value
    		 60.97M 50.54M 61.87M 88M
    Book Value Per Share
    		 0.41 0.38 0.51 0.75
    Common Stock
    		 3.06M 2.77M 1.88M 1.75M
    Retained Earnings
    		 -462.88M -419.63M -331.16M -296.97M
    Comprehensive Income
    		 -18.85M -17.48M 137.91M 136.9M
    Shareholders Equity
    		 60.97M 50.54M 61.87M 88M
    Total Investments
    		 n/a n/a 51.1M 569K

    Add to Watchlist